Keane Raymond T 4
4 · Cullinan Oncology, Inc. · Filed Feb 15, 2022
Insider Transaction Report
Form 4
Keane Raymond T
Chief Legal Officer
Transactions
- Award
Common Stock
2022-02-11+22,500→ 24,124 total - Award
Stock Option (Right to Buy)
2022-02-11+45,000→ 45,000 totalExercise: $13.60Exp: 2032-02-10→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]The shares underlying the restricted stock unit vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.
- [F2]The shares underlying the option vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date.